LP-003 not checked

Longbio Pharma

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
8 active
11 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Participants were administered LP-003 via subcutaneous injection every 4 weeks.”In the company’s words, NCT07291284 on ClinicalTrials.gov
Tested for
Seasonal Allergic Rhinitis, Chronic Spontaneous Urticaria (CSU), Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Food Allergy, Wheat Hypersensitivity, Allergic Asthma, Peanut Allergies, Allergic Diseases and 1 more
Main trialPhase 3
“This is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study to evaluate the efficacy and safety of LP-003 injection in patients with moderate to severe seasonal allergic rhinitis inadequately controlled by standard-of-care.”In the company’s words, NCT07291284 on ClinicalTrials.gov

Other drugs for Seasonal Allergic Rhinitis

All 11 drugs for Seasonal Allergic Rhinitis

Coming up6

Changes1

Last 90 days

Trials11

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 31 Mar 2026 Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis
Phase 3Not yet recruiting 24 Mar 2028 A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite Treatment With H1 Antihistamines
Phase 2Not yet recruiting 28 Feb 2027 A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Phase 2Not yet recruiting 16 Jul 2027 A Study to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Characteristics of LP-003 Injection in Participants With Wheat Allergy
Phase 2Recruiting 28 Dec 2027 Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Phase 2Not yet recruiting May 2029 Efficacy, Safety and Pharmacokinetics of LP-003 in Peanut Allergic Patients
Phase 1/2Active, not recruiting 31 May 2026 A Study of Single Dose of LP-003 in Adolescent Subjects
Phase 1Active, not recruiting Nov 2026 A Study of Single Dose of LP-003 in Healthy Adult Subjects
Phase 2Completed 19 Oct 2023 Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult
Phase 2Completed 17 Apr 2025 Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment
Phase 1Completed 4 Mar 2024 A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow LP-003

Following is part of Solo: you see every change to LP-003 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in